Dalong Biotech has long been committed to biotech innovation and practical application — and today, we have exciting news to share. Our project, “Product Development of Sleep-Active Compounds in Cordyceps militaris via a Biphasic Immobilization Dual-Stage Cultivation System,” has been officially approved under the Ministry of Economic Affairs Industrial Development Administration’s FY2026 Collaborative Industry-Technology Development (CITD) Program.This recognition affirms both the depth of Dalong’s technical R&D capabilities and our commitment to improving quality of life.
In today’s fast-paced world, quality sleep has become a precious commodity. Dalong Biotech understands that single-compound or chemically-added products often fail to address complex physiological needs. That’s why this project centers on our exclusive Biphasic Immobilization + Dual-Stage Fermentation Technology — a proprietary process that enables Cordyceps militaris to naturally produce a full spectrum of bioactive compounds during cultivation, including GABA, adenosine, cordycepin, and polysaccharides.Together, these form a “Native Multi-Compound Synergistic System” of rare functional value.
Unlike conventional compound-added sleep products on the market, this approach emphasizes “inside-out” physiological balance. Through precision process control, key bioactives achieve their natural optimal ratio during the fermentation stage itself — addressing the complete sleep cycle from drowsiness to sleep onset to deep sleep.The result is a gentler, more natural-rhythm experience that aligns with the body’s own biology, making it particularly well-suited for consumers with long-term health maintenance needs.
Furthermore, the manufacturing process developed through this project is highly scalable and standardized, ensuring consistent quality across every production batch. At Dalong Biotech, we believe technology’s greatest value lies in solving real-life challenges. Going forward, we will continue to embody the spirit of the CITD program — translating this technically sophisticated and difficult-to-replicate R&D achievement into tangible products that help people reclaim their natural ability to sleep and live a higher-quality, healthier life.
In today’s fast-paced world, quality sleep has become a precious commodity. Dalong Biotech understands that single-compound or chemically-added products often fail to address complex physiological needs. That’s why this project centers on our exclusive Biphasic Immobilization + Dual-Stage Fermentation Technology — a proprietary process that enables Cordyceps militaris to naturally produce a full spectrum of bioactive compounds during cultivation, including GABA, adenosine, cordycepin, and polysaccharides.Together, these form a “Native Multi-Compound Synergistic System” of rare functional value.
Unlike conventional compound-added sleep products on the market, this approach emphasizes “inside-out” physiological balance. Through precision process control, key bioactives achieve their natural optimal ratio during the fermentation stage itself — addressing the complete sleep cycle from drowsiness to sleep onset to deep sleep.The result is a gentler, more natural-rhythm experience that aligns with the body’s own biology, making it particularly well-suited for consumers with long-term health maintenance needs.
Furthermore, the manufacturing process developed through this project is highly scalable and standardized, ensuring consistent quality across every production batch. At Dalong Biotech, we believe technology’s greatest value lies in solving real-life challenges. Going forward, we will continue to embody the spirit of the CITD program — translating this technically sophisticated and difficult-to-replicate R&D achievement into tangible products that help people reclaim their natural ability to sleep and live a higher-quality, healthier life.
